{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:04:40Z","timestamp":1782781480976,"version":"3.54.5"},"reference-count":40,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Despite the availability of antibiotic therapy, tuberculosis (TB) is prevailing as a leading killer among human infectious diseases, which highlights the need for better intervention strategies to control TB. Several animal model systems, including mice, guinea pigs, rabbits, and non-human primates have been developed and explored to understand TB pathogenesis. Although each of these models contributes to our current understanding of host-Mycobacterium tuberculosis (Mtb) interactions, none of these models fully recapitulate the pathological spectrum of clinical TB seen in human patients. Recently, humanized mouse models are being developed to improvise the limitations associated with the standard mouse model of TB, including lack of necrotic caseation of granulomas, a pathological hallmark of TB in humans. However, the spatial immunopathology of pulmonary TB in humanized mice is not fully understood. In this study, using a novel humanized mouse model, we evaluated the spatial immunopathology of pulmonary Mtb infection with a low-dose inoculum. Humanized NOD\/LtSscidIL2R\u03b3 null mice containing human fetal liver, thymus, and hematopoietic CD34+ cells and treated with human cytokines were aerosol challenged to implant &lt;50 pathogenic Mtb (low dose) in the lungs. At 2 and 4 weeks post infection, the tissue bacterial load, disease pathology, and spatial immunohistology were determined in the lungs, liver, spleen, and adipose tissue using bacteriological, histopathological, and immunohistochemical techniques. The results indicate that implantation of &lt;50 bacteria can establish a progressive disease in the lungs that transmits to other tissues over time. The disease pathology in organs correspondingly increased with the bacterial load. A distinct spatial distribution of T cells, macrophages, and natural killer cells were noted in the lung granulomas. The kinetics of spatial immune cell distribution were consistent with the disease pathology in the lungs. Thus, the novel humanized model recapitulates several key features of human pulmonary TB granulomatous response and can be a useful preclinical tool to evaluate potential anti-TB drugs and vaccines.<\/jats:p>","DOI":"10.3390\/ijms25031656","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T08:54:03Z","timestamp":1706518443000},"page":"1656","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunopathology of Pulmonary Mycobacterium tuberculosis Infection in a Humanized Mouse Model"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0715-454X","authenticated-orcid":false,"given":"Afsal","family":"Kolloli","sequence":"first","affiliation":[{"name":"Public Health Research Institute, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0035-8729","authenticated-orcid":false,"given":"Ranjeet","family":"Kumar","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-1160","authenticated-orcid":false,"given":"Vishwanath","family":"Venketaraman","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2021-8632","authenticated-orcid":false,"given":"Selvakumar","family":"Subbian","sequence":"additional","affiliation":[{"name":"Public Health Research Institute, Rutgers-New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2023). Global Tuberculosis (TB) Report, World Health Organization."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Houben, R.M., and Dodd, P.J. (2016). The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002152"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1016\/S1473-3099(18)30134-8","article-title":"Progression from latent infection to active disease in dynamic tuberculosis transmission models: A systematic review of the validity of modelling assumptions","volume":"18","author":"Menzies","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e060906","DOI":"10.1136\/bmjopen-2022-060906","article-title":"Prevalence and risks of tuberculosis multimorbidity in low-income and middle-income countries: A meta-review","volume":"12","author":"Jarde","year":"2022","journal-title":"BMJ Open"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.ijid.2023.03.013","article-title":"Update of drug-resistant tuberculosis treatment guidelines: A turning point","volume":"130","author":"Vanino","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1146\/annurev-immunol-093019-125148","article-title":"The Tuberculous Granuloma and Preexisting Immunity","volume":"40","author":"Cohen","year":"2022","journal-title":"Annu. Rev. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"C1444","DOI":"10.1152\/ajpcell.00246.2022","article-title":"Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection","volume":"323","author":"Nisa","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1264833","DOI":"10.3389\/fvets.2023.1264833","article-title":"Comparative pathology of experimental pulmonary tuberculosis in animal models","volume":"10","author":"Hunter","year":"2023","journal-title":"Front. Vet. Sci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"102377","DOI":"10.1016\/j.tube.2023.102377","article-title":"The Many Hosts of Mycobacteria 9 (MHM9): A conference report","volume":"142","author":"Klever","year":"2023","journal-title":"Tuberculosis"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"ftz037","DOI":"10.1093\/femspd\/ftz037","article-title":"The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease","volume":"77","author":"Bucsan","year":"2019","journal-title":"Pathog. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Yang, H.J., Wang, D., Wen, X., Weiner, D.M., and Via, L.E. (2021). One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.613149"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e20210332","DOI":"10.1084\/jem.20210332","article-title":"Genetic models of latent tuberculosis in mice reveal differential influence of adaptive immunity","volume":"218","author":"Su","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.ajpath.2012.07.019","article-title":"Spontaneous latency in a rabbit model of pulmonary tuberculosis","volume":"181","author":"Subbian","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhan, L., Tang, J., Sun, M., and Qin, C. (2017). Animal Models for Tuberculosis in Translational and Precision Medicine. Front. Microbiol., 8.","DOI":"10.3389\/fmicb.2017.00717"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-023-00623-z","article-title":"Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice","volume":"8","author":"Afkhami","year":"2023","journal-title":"NPJ Vaccines"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fimmu.2019.00089","article-title":"Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens","volume":"10","author":"Arrey","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12977-021-00559-z","article-title":"Advancing our understanding of HIV co-infections and neurological disease using the humanized mouse","volume":"18","author":"Endsley","year":"2021","journal-title":"Retrovirology"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gong, W., Liang, Y., and Wu, X. (2020). Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis. Biomed. Res. Int., 2020.","DOI":"10.1155\/2020\/4263079"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Lepard, M., Yang, J.X., Afkhami, S., Nazli, A., Zganiacz, A., Tang, S., Choi, M.W.Y., Vahedi, F., Deshiere, A., and Tremblay, M.J. (2022). Comparing Current and Next-Generation Humanized Mouse Models for Advancing HIV and HIV\/Mtb Co-Infection Studies. Viruses, 14.","DOI":"10.3390\/v14091927"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"RP87431","DOI":"10.7554\/eLife.87431","article-title":"Vaccination with mycobacterial lipid loaded nanoparticle leads to lipid antigen persistence and memory differentiation of antigen-specific T cells","volume":"12","author":"Morgun","year":"2023","journal-title":"eLife"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Calderon, V.E., Valbuena, G., Goez, Y., Judy, B.M., Huante, M.B., Sutjita, P., Johnston, R.K., Estes, D.M., Hunter, R.L., and Actor, J.K. (2013). A humanized mouse model of tuberculosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0063331"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"666290","DOI":"10.3389\/fimmu.2021.666290","article-title":"Peptides-Based Vaccine MP3RT Induced Protective Immunity Against Mycobacterium tuberculosis Infection in a Humanized Mouse Model","volume":"12","author":"Gong","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/imm.12756","article-title":"Humanized NOG mice as a model for tuberculosis vaccine-induced immunity: A comparative analysis with the mouse and guinea pig models of tuberculosis","volume":"152","author":"Grover","year":"2017","journal-title":"Immunology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41467-020-20600-7","article-title":"Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy","volume":"12","author":"Somasundaram","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/icb.1997.68","article-title":"The role of CD45 and CD45-associated molecules in T cell activation","volume":"75","author":"Altin","year":"1997","journal-title":"Immunol. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijid.2005.06.012","article-title":"Clinical correlates of tuberculosis co-infection in HIV-infected children hospitalized in Peru","volume":"10","author":"Kawai","year":"2006","journal-title":"Int. J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3389\/fimmu.2019.00917","article-title":"The Emerging Role of Myeloid-Derived Suppressor Cells in Tuberculosis","volume":"10","author":"Magcwebeba","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/jor1040023","article-title":"Immune Correlates of Non-Necrotic and Necrotic Granulomas in Pulmonary Tuberculosis: A Pilot Study","volume":"1","author":"Subbian","year":"2021","journal-title":"J. Respir."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Abnousian, A., Vasquez, J., Sasaninia, K., Kelley, M., and Venketaraman, V. (2023). Glutathione Modulates Efficacious Changes in the Immune Response against Tuberculosis. Biomedicines, 11.","DOI":"10.20944\/preprints202304.0166.v1"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/infdis\/jiaa708","article-title":"Harmful Effects of Granulocytic Myeloid-Derived Suppressor Cells on Tuberculosis Caused by Hypervirulent Mycobacteria","volume":"223","author":"Hastreiter","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/JLB.4A0720-409RR","article-title":"Monocytic myeloid-derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase-2 inhibitors","volume":"110","author":"Jenum","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1164\/rccm.201405-0828OC","article-title":"Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis","volume":"190","author":"Knaul","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/infdis\/jiv055","article-title":"Interferon gamma and Tumor Necrosis Factor Are Not Essential Parameters of CD4+ T-Cell Responses for Vaccine Control of Tuberculosis","volume":"212","author":"Orr","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cyto.2012.06.012","article-title":"Interferon-gamma, tumor necrosis factor, and interleukin-18 cooperate to control growth of Mycobacterium tuberculosis in human macrophages","volume":"60","author":"Robinson","year":"2012","journal-title":"Cytokine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/ijmy.ijmy_63_20","article-title":"Plasma levels of tumor necrosis factor-alpha, interferon-gamma, inducible nitric oxide synthase, and 3-nitrotyrosine in drug-resistant and drug-sensitive pulmonary tuberculosis patients, Ibadan, Nigeria","volume":"9","author":"Bolajoko","year":"2020","journal-title":"Int. J. Mycobacteriol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cbf.1039","article-title":"Lipid peroxidation, vitamins C, E and reduced glutathione levels in patients with pulmonary tuberculosis","volume":"22","author":"Vijayamalini","year":"2004","journal-title":"Cell Biochem. Funct."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"602589","DOI":"10.3389\/fimmu.2020.602589","article-title":"Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial","volume":"11","author":"Safe","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Kachour, N., Beever, A., Owens, J., Cao, R., Kolloli, A., Kumar, R., Sasaninia, K., Vaughn, C., Singh, M., and Truong, E. (2022). Liposomal Glutathione Helps to Mitigate Mycobacterium tuberculosis Infection in the Lungs. Antioxidants, 11.","DOI":"10.3390\/antiox11040673"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1270414","DOI":"10.3389\/fimmu.2023.1270414","article-title":"A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection","volume":"14","author":"Kolloli","year":"2023","journal-title":"Front. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/3\/1656\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:51:16Z","timestamp":1760104276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/3\/1656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":40,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["ijms25031656"],"URL":"https:\/\/doi.org\/10.3390\/ijms25031656","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]}}}